Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

Sanguine Biosciences1 site in 1 country6 target enrollmentMay 23, 2023

ConditionsChronic Granulomatous Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Granulomatous Disease
Sponsor: Sanguine Biosciences
Enrollment: 6
Locations: 1
Primary Endpoint: Participants have been diagnosed with Chronic Granulomatous Disease (CGD)
Status: Terminated
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Chronic Granulomatous Disease (CGD). The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling. The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research.

Registry

clinicaltrials.gov

Start Date

May 23, 2023

End Date

March 25, 2024

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Sanguine Biosciences

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•The participant is willing and able to provide written informed consent
•The participant is willing and able to provide appropriate photo identification
•Participants aged 18 to 85
•Participants have been diagnosed with Chronic Granulomatous Disease (CGD)
•Subjects who have a confirmed p47phox CGD mutation or Subjects who have a confirmed X-linked CGD mutation

Exclusion Criteria

•Participants who are pregnant or are nursing
•Participants with a known history of HIV, hepatitis, or other infectious diseases
•Participants who have taken an investigational product in the last 30 days
•Participants who have experienced excess blood loss, including blood donation, defined as 250 mL in the last month or 500 mL in the previous two months